Jump to main content
Jump to site search

Issue 1, 2008
Previous Article Next Article

A microfluidic bioreactor for increased active retrovirus output

Author affiliations


Retroviruses are one of the most commonly used vectors in ongoing gene therapy clinical trials. To evaluate and advance virus production on the microscale platform, we have created a novel microfluidic bioreactor for continuous retrovirus production. We investigated the growth kinetics of a retroviral packaging cell line in microfluidic bioreactors for several compartment sizes, and packaging cells perfused in the microdevices showed similar growth kinetics to those cultured in conventional static conditions. To evaluate the efficiency of retrovirus production, virus titers from the microdevices were compared to those obtained from static tissue culture. When retrovirus production and collection were maintained at 37 °C, virus production levels were comparable for the microdevices and static tissue culture conditions. However, immediate cold storage downstream of the packaging cells in the microdevices resulted in 1.4- to 3.7-fold greater active virus production levels with the microdevices compared to the conventional static conditions over a 5 day period. Lastly, the use of microfluidics for virus production provides a continuous supply of virus supernatant for immediate infection of target cells or for preservation and storage. Such devices will be valuable for the optimization of production and evaluation of retroviruses and other viral vectors for gene therapy applications.

Graphical abstract: A microfluidic bioreactor for increased active retrovirus output

Back to tab navigation

Article information

30 Jul 2007
09 Oct 2007
First published
30 Oct 2007

Lab Chip, 2008,8, 75-80
Article type

A microfluidic bioreactor for increased active retrovirus output

H. N. Vu, Y. Li, M. Casali, D. Irimia, Z. Megeed and M. L. Yarmush, Lab Chip, 2008, 8, 75
DOI: 10.1039/B711577F

Social activity

Search articles by author